Phosphate and carbonate salts of calcium support robust bone building in osteoporosis

American Journal of Clinical Nutrition

Volumn 92, Issue 1, 2010, Pages 101-105

  Heaney, Robert P ^a   Recker, Robert R ^a   Watson, Patrice ^a   Lappe, Joan M ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CALCIUM CARBONATE; CALCIUM PHOSPHATE; COLECALCIFEROL; PARATHYROID HORMONE[1-34]; PHOSPHORUS; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; BONE DENSITY; BONE DEVELOPMENT; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CREATININE URINE LEVEL; DRUG DOSE REDUCTION; FEMALE; HIP; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; BLOOD; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; POSTMENOPAUSE OSTEOPOROSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TABLET;

ADMINISTRATION, ORAL; AGED; BODY MASS INDEX; BONE DENSITY; BONE DEVELOPMENT; CALCIUM; CALCIUM CARBONATE; CALCIUM PHOSPHATES; CHOLECALCIFEROL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT SELECTION; SINGLE-BLIND METHOD; TABLETS;

EID: 77954581474     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.29085     Document Type: Article

References (9)

1. Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals, and fiber of persons 2 months and over in the United States: Third National Health and Nutrition Examination Survey, phase 1, 1988-91. Advance data from vital and health statistics; no. 258. Hyattsville, MD: National Center for Health Statistics, 1994.
2. Heaney RP. Phosphorus nutrition and the treatment of osteoporosis. Mayo Clin Proc 2004;79:91-7.
3. Hutchison AJ. Oral phosphate binders. Kidney Int 2009;75:906-14.
4. Bergman L, Loxley R. The determination of hydroxyproline in urine hydrolysates. Chim Acta 1970;27:347-9.
5. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
6. Rüegsegger P, Keller A, Dambacher MA. Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporos Int 1995;5:30-4.
7. Pines A, Raafat H, Lynn AH, Whittington J. Clinical trial of microcrystalline hydroxyapatite compound (Ossopan) in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin 1984;8:734-42. (Pubitemid 14173283)
8. Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in post-menopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982;36:426-30. (Pubitemid 12002235)
9. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.